Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Verhoogd risico op pancreascarcinoom na HCV-infectie
dec 2025 | Hepatitis, Maag-darm-leveroncologie, Virale infecties